GNTLF
Genetic Technologies Ltd.

3
Loading...
Loading...
Genetic Technologies Ltd. engages in the provision of molecular risk assessment tests for cancer. It operates through the following segments: EasyDNA, AffinityDNA, and GeneType/Corporate. The EasyDNA segment focuses on EasyDNA branded test sales and expenses. The AffinityDNA segment deals with AffinityDNA branded test sales and expenses. The GeneType/Corporate segment includes the GeneType branded test sales and expenses, including corporate charges. The company was founded on January 5, 1987, and is headquartered in Fitzroy, Australia.
Sector:
Commercial Services
Industry:
Miscellaneous Commercial Services
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Genetic Technologies Ltd.?
What is the 52-week high for Genetic Technologies Ltd.?
What is the 52-week low for Genetic Technologies Ltd.?
What was Genetic Technologies Ltd. stock price yesterday?
What is the PE ratio of Genetic Technologies Ltd.?
What is the Price-to-Book ratio of Genetic Technologies Ltd.?
What is the 50-day moving average of Genetic Technologies Ltd.?

Latest GNTLF News

View
No GNTLF news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.